| Executive Directors |
Non-Executive Directors |
 |
 |
| Independent Non-Executive Directors |
 |
Executive Directors
Mr. Wang Fucai (王福才先生), is the founder, the chairman of the board of directors and the chief executive officer of the Company and is responsible for the overall management, strategic development and major decision making of the Group. Mr. Wang was appointed as an executive Director of the Company on August 30, 2006. Mr. Wang received a graduation certificate (畢業證) from the Medical Department of Harbin Medical University (哈爾濱醫科大學) in July 1983. Mr. Wang established Wuxi Ruinian Industry and Commerce Co. Ltd. (“Ruinian Industry”) in 1997 to develop his own business and is now the chairman and general manager of Ruinian Industry. He is an associate director of China Food and Drug Administration Magazine (國家食品藥品監督管理局監督雜誌) and a permanent member of the Association of Hong Kong & Kowloon Practitioners of Chinese Medicine Limited. Mr. Wang possesses almost 30 years of experience in the health care and pharmaceutical industry, including over 10 years in the nutritional supplement industry. Mr. Wang served in BeiMan TeGang and its affiliated hospital (北滿特鋼及其附屬醫院), a state-owned entity, from 1983 to 1992 and was appointed as the Medical Superintendent from 1990 to 1992, during which he gained experiences in management and administration. From 1992 to 1997, Mr. Wang worked in Shenzhen Hygienic Development Company (深圳市衛生發展公司) as the general manager and was responsible for the sale of pharmaceutical products.

Mr. Yu Yan (于岩先生), is an executive Director and is responsible for the Group’s production and administration. Mr. Yu was appointed as an executive Director of the Company on August 30, 2006. Mr. Yu has over 23 years of experience in management. He was the supervisor and factory manager of Northern Steel Development Factory (北鋼北發工業公司) and its subsidiary from 1986 to 1996. Mr. Yu joined the Group in December 1997 and is currently the deputy general manager of Ruinian Industry.

Mr. Li Lin (李林先生), is an executive Director and is responsible for the sales and marketing of the Group. Mr. Li was appointed as an executive Director of the Company on August 30, 2006. Mr. Li is a senior economist recognized by the Department of Personnel of Jiangsu Province based on the assessment by Jiangsu Qualification Evaluation Committee of Senior Professional Positions Specialised in Economic Field (江蘇省經濟專業高級專業技術資格評審委員會). He graduated from Hubei University (湖北大學) in July 1989 and obtained an executive MBA degree from Peking University (北京大學) in January 2007. He was employed by Wuhan Standard Vehicle Parts Factory (武漢汽車標準件廠) as a teacher, administrator of student affairs department and plant manager during the period between 1989 and 1995. He worked for Sanzhu Group Limited (三株集團有限公司) as a manager, regional manager and sales director until 2000 and has over 14 years of experience in sales and marketing. Mr. Li joined the Group in October 2000 and is currently the deputy general manager of Ruinian Industry.

Mr. Yi Lin (伊林先生), is an executive Director and is responsible for the product development and administration of the Group. Mr. Yi was appointed as an executive Director of the Company on August 30, 2006. Mr. Yi obtained a Bachelor’s Degree in Pharmaceutical Preparation (製劑) from Shenyang Medical University ( 瀋陽藥科大學) in 1987. During the period between 1987 and 1993, he was employed by Harbin Pharmaceutical Group (哈藥集團股份有限公司) and later promoted to be a sales manager. Mr. Yi was the head of sales of Shenzhen Bright Way Pharmaceutical Co., Ltd. ( 深圳凱程醫藥化工有限公司) during the period between 1993 and 1998 and the provincial, regional and Northern China regional manager of Shenzhen Xinpeng Biological Engineering Ltd. (深圳新鵬生物工程有限公司) during the period between 1998 and 2004. He has approximately 21 years of experience in sales and marketing. Mr. Yi joined the Group in February 2004 and is currently the deputy general manager of Ruinian Industry.

Mr. Zhang Yan (張宴先生), is an executive Director and is responsible for the finance and treasury of the Group. Mr. Zhang was appointed as an executive Director of the Company on August 30, 2006. Mr. Zhang completed a diploma study (大學專科) in Finance and Accounting from Shanghai University of Finance & Economics (上海財經大學) in July 1996. He joined Wuxi Desheng Silk Plant (無錫市德生綢廠) in September 1996 and was later promoted as an administrator of the human resources and accounts department. He has accumulated over 12 years of experience in accounting. Mr. Zhang joined the Group in January 2001 and is currently the deputy general manager of Ruinian Industry.

Ms. Au-yeung Kam Ling Celeste (歐陽錦玲女士), is an executive Director and is responsible for the operations of the Group outside the PRC. Ms. Au-yeung joined the Group in October 2004. Ms. Au-yeung was appointed as an executive Director of the Company on March 28, 2008. Ms. Au-yeung has approximately 18 years of experience in the health food industry. Ms. Au-yeung worked in Sunrider International (Hong Kong) Ltd., an international health food company from 1991 to 2001, where she was promoted to district operation manager and gained extensive knowledge and experience in the health food markets in Hong Kong and Southeast Asia. Prior to joining the Group, she worked as operation manager in both Ta Shing Indomold from 2001 to 2003 and Majestic Group from 2003 to 2004. Ms. Au-yeung completed a study in Journalism from Chu Hai College (珠海書院) in Hong Kong in 1986.

Non-Executive Directors
Mr. IP Tak Chuen, Edmond (葉德銓先生), is a non-executive Director and joined the Group in October 2007. Mr. Ip was appointed as a non-executive Director of the Company on March 28, 2008. Mr. Ip is a senior management member at a number of companies. The following chart summarises Mr. Ip’s positions at such companies:

| Company(1) |
Position |
CK Life Sciences Int’l., (Holdings) Inc. (“CK Life Sciences”)(2)
|
Senior vice president and chief investment officer
|
Cheung Kong (Holdings) Limited(3)
|
Deputy managing director
|
Cheung Kong Infrastructure Holdings Limited
|
Executive and deputy chairman
|
TOM Group Limited
|
Non-executive director
|
ARA Asset Management Limited
|
Non-executive director
|
AVIC International Holding (HK) Limited
|
Non-executive director
|
| Excel Technology International Holdings Limited |
Non-executive director
|
| Shougang Concord International Enterprises Company Limited |
Non-executive director
|
ARA Asset Management (Fortune) Limited(4),
the manager of Fortune Real Estate Investment Trust
|
Non-executive director
|
|
ARA Trust Management (Suntec) Limited,
the manager director of Suntec Real Estate Investment Trust
|
Director |
Notes:
(1) All the above are listed companies or REITs listed in Hong Kong and/or Singapore.
(2) CK Life Sciences is a company listed on the Main Board of the Stock Exchange. Mr. Ip
joined the CK Life Sciences Group in December 1999.
(3) Mr. Ip joined the Cheung Kong Group in 1993.
(4) The company was formerly known as ARA Assets Management (Singapore) Limited.
Mr. Ip obtained a Bachelor of Arts degree in Economics in 1975 and a Master of Science degree in Business Administration in 1977.

Mr. Tsang Sze Wai Claudius, CFA (曾思維先生), is a non-executive Director and joined the Group in May 2010. Mr. Tsang was appointed as a non-executive Director of the Company on May 26, 2010. Mr. Tsang first joined Templeton Assets Management Limited in July 2005. He is now the vice president and executive director of Templeton Asset Management Limited. Mr. Tsang is a chartered financial analyst. He had 12 years’ experience in investment management industry and served various positions in Jardine Fleming Securities Asia Limited, Chinachem Group, Korean Development Bank and Lehman Brothers. Mr. Tsang obtained a Bachelor Degree in Engineering from The Chinese University of Hong Kong in 1998 and a Bachelor of Law degree from Tsinghua University in 2006. He is a holder of a Chartered Financial Analyst charter of the CFA Institute.

Independent Non-Executive Directors
Dr. Wong Lung Tak Patrick, BBS, J.P. (黃龍德先生), is an independent non-executive Director and joined the Group in March 2008. Dr. Wong was appointed as an independent non-executive Director of the Company on March 28, 2008. Dr. Wong is a Certified Public Accountant (Practising) in Hong Kong and the managing practising director of Patrick Wong CPA Limited, Wong Lam Leung & Kwok CPA Limited and Hong Kong Pengcheng CPA Limited. He has over 30 years experience in the accountancy profession. Dr. Wong holds a Doctor of Philosophy in Business degree, was awarded a Badge of Honour by the Queen of England in 1993 and was appointed a Justice of the Peace in 1998. He was also awarded a Bronze Bauhinia Star by the Government of the HKSAR in 2010. He has been appointed Adjunct Professor, School of Accounting and Finance of the Hong Kong Polytechnic University since 2002. Dr. Wong participates in many types of community services and is holding posts in various organisations and committees in government and voluntary agencies. Dr. Wong is an independent non-executive director of China Precious Metal Resources Holdings Co., Ltd., C C Land Holdings Limited, Water Oasis Group Limited, Sino Oil and Gas Holdings Limited, Galaxy Entertainment Group Limited and Guangzhou Pharmaceutical Company Limited, all of which are listed on the Main Board of the Stock Exchange. Dr. Wong has been appointed as an independent non-executive director of National Arts Holdings Limited (listed on the Growth Enterprise Market of the Stock Exchange) with effect from 3 February 2010.

Dr. Fong Chi Wah (方志華博士), is an independent non-executive Director and joined the Group in March 2008. Dr. Fong was appointed as an independent non-executive Director of the Company on March 28, 2008. Dr. Fong is a Chartered Financial Analyst, a member of Hong Kong Institute of CPAs and the Institute of Certified Management Accountants, Australia, and the Hong Kong Institute of Directors. Dr. Fong has over 21 years of experience in various sectors of the financial industry, including direct investment, project and structured finance and capital markets, with a focus on the PRC and Hong Kong. Dr. Fong was a director of Baring Capital (China) Management Limited and held various management positions in ING Bank. He was appointed as an independent non-executive director of Syscan Technology Holdings Limited on December 19, 2003 and as an executive director of National Investments Fund Limited on November 1, 2005, and both companies are listed on the Stock Exchange. Dr. Fong obtained a Bachelor’s Degree in Management Science (economics) from Lancaster University, United Kingdom, in 1984, a master’s degree in business administration from Warwick University, United Kingdom, in 1986, a master’s degree in investment management from the Hong Kong University of Science and Technology in 1999, a master’s degree in practising accounting from Monash University, Australia, in 2001 and a doctorate in business administration from the Hong Kong Polytechnic University in 2007.

Mr. Bernard Ban-yew Yaw (饒萬有先生), is an independent non-executive Director and joined the Group in November 2009. Mr. Yaw was appointed as an independent non-executive Director of the Company on November 2, 2009. Mr. Yaw has over 21 years of management and investment experiences. He is the chief executive officer of Asiante Capital Management Sdn. Bhd., an investment advisory and fund management company, located in Kuala Lumpur. Mr. Yaw joined Dubai Ventures Group Sdn Bhd (“DVG”) as executive director and head of private equity since December 1, 2005. DVG is a wholly owned subsidiary of Dubai Group, whose sole shareholder is HH Sheikh Mohammed bin Rashid Al-Maktoum who was the ruler of Dubai and the Prime Minister of the United Arab Emirates. DVG was the regional office for Dubai Investment Group in Kuala Lumpur and its primary investment focus was equity investment in this region including Malaysia, Singapore, Thailand, Indonesia, Vietnam, Philippines, Australasia, and North Asia including China. DVG had regional offices in Kuala Lumpur, Hong Kong, London, and New York with its headquarters at Dubai, UAE. Prior to joining DVG, Mr. Yaw was with Malaysia Ventures Capital Management Berhad (“MAVCAP”), a wholly owned subsidiary of the Ministry of Finance Inc. Malaysia, which was the investment arm of the Malaysian Government, in various capacities. He was the senior vice president of direct ventures, in charge of seed ventures and agency ventures and was in charge of the strategic implementation of the Cradle Investment Program since MAVCAP’s inception in April 2001. Prior to joining MAVCAP, he was the president and CEO of Intelliquis Inc., a NASDAQ listed company in which he was in charge of raising early and later stages capital, strategic corporate and worldwide expansion and ultimately the listing exercise in NASDAQ. Mr. Yaw graduated from Oral Roberts University in 1985 with a Bachelor of Science degree in computer science.

Mr. Chan Kee Ming, William (陳基明先生), is an independent non-executive Director and joined the Group in May 2010. Mr. Chan was appointed as an independent non-executive Director of the Company on May 26, 2010. Mr. Chan is the honorable secretary of The Hong Kong Software Industry Association since 2008. Mr. Chan was the account executive of Federal Express Limited in 1990 and the general manager of Vanda Computer and Equipment Co Ltd from 1992 to 2000. Mr. Chan has over 11 years’ experience in logistic business. From 2002 to 2009, Mr. Chan was a fellow member of the E-logistics Group and S-logistics Group of the Logistics Development Council of Hong Kong. Mr. Chan has been the chief executive officer of Digi Logistics Technology Limited since January 2000. Mr. Chan obtained a Bachelor of Arts degree from The University of Hong Kong in 1987.

|